![Matthew Killeen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Killeen
Technik-/Wissenschafts-/F&E-Leiter bei
RENOVACOR, INC.
Profil
Matthew Killeen is currently the Director at Sudden Cardiac Arrest Foundation, Advisor-Scientific Affairs at CREAGRI, Inc., and Chief Scientific Officer at Renovacor, Inc. He previously worked as the Head-Cardiovascular Research at BioMarin Pharmaceutical, Inc. and as a Principal at Eli Lilly & Co. Ltd. Killeen holds a doctorate degree from the University of Cambridge and an undergraduate degree from the University of Leeds.
Aktive Positionen von Matthew Killeen
| Unternehmen | Position | Beginn |
|---|---|---|
| RENOVACOR, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2021 |
CREAGRI, Inc.
 CREAGRI, Inc. Food RetailRetail Trade Develops and supplies antioxidant polyphenols | Corporate Officer/Principal | 12.05.2011 |
Sudden Cardiac Arrest Foundation
 Sudden Cardiac Arrest Foundation Miscellaneous Commercial ServicesCommercial Services Sudden Cardiac Arrest Foundation is a national community benefit organization that aims to eliminate preventable death and disability from sudden cardiac arrest. The company supports individuals affected by SCA and raise awareness through education, research, and community initiatives. The company is located in the US. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Matthew Killeen
| Unternehmen | Position | Ende |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Eli Lilly & Co. Ltd.
 Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical health care solutions | Corporate Officer/Principal | - |
Ausbildung von Matthew Killeen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
6
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Leeds
 University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eli Lilly & Co. Ltd.
Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical health care solutions | Health Technology |
CREAGRI, Inc.
CREAGRI, Inc. Food RetailRetail Trade Develops and supplies antioxidant polyphenols | Retail Trade |
Renovacor, Inc.
 Renovacor, Inc. BiotechnologyHealth Technology Engages in research and development for precision gene therapies and genetically driven cardiovascular diseases | Health Technology |
Sudden Cardiac Arrest Foundation
Sudden Cardiac Arrest Foundation Miscellaneous Commercial ServicesCommercial Services Sudden Cardiac Arrest Foundation is a national community benefit organization that aims to eliminate preventable death and disability from sudden cardiac arrest. The company supports individuals affected by SCA and raise awareness through education, research, and community initiatives. The company is located in the US. | Commercial Services |
